Hideshi Torii

Summary

Country: Japan

Publications

  1. doi request reprint Dramatic impact of a Psoriasis Area and Severity Index 90 response on the quality of life in patients with psoriasis: an analysis of Japanese clinical trials of infliximab
    Hideshi Torii
    Division of Dermatology, Social Insurance Central General Hospital, Tokyo, Japan
    J Dermatol 39:253-9. 2012
  2. ncbi request reprint Clinical and bacteriological evaluation of adapalene 0.1% gel plus nadifloxacin 1% cream versus adapalene 0.1% gel in patients with acne vulgaris
    Masahiro Takigawa
    Hamamatsu University School of Medicine, Tokyo, Japan
    J Dermatol 40:620-5. 2013
  3. ncbi request reprint Dermatological side-effects of telaprevir-based triple therapy for chronic hepatitis C in phase III trials in Japan
    Hideshi Torii
    Division of Dermatology, Social Insurance Central General Hospital, Tokyo, Japan
    J Dermatol 40:587-95. 2013
  4. doi request reprint Infliximab monotherapy in Japanese patients with moderate-to-severe plaque psoriasis and psoriatic arthritis. A randomized, double-blind, placebo-controlled multicenter trial
    Hideshi Torii
    Division of Dermatology, Social Insurance Central General Hospital, and Department of Dermatology, The Jikei University School of Medicine, 3 22 1 Hyakunincho, Shinjyuku, Tokyo 169 0073, Japan
    J Dermatol Sci 59:40-9. 2010
  5. ncbi request reprint Long-term study of infliximab in Japanese patients with plaque psoriasis, psoriatic arthritis, pustular psoriasis and psoriatic erythroderma
    Hideshi Torii
    Division of Dermatology, Social Insurance Central General Hospital, Tokyo, Japan
    J Dermatol 38:321-34. 2011
  6. ncbi request reprint The -431C>T polymorphism of thymus and activation-regulated chemokine increases the promoter activity but is not associated with susceptibility to atopic dermatitis in Japanese patients
    Yuichiro Tsunemi
    Department of Dermatology, Faculty of Medicine, University of Tokyo, Tokyo, Japan
    Exp Dermatol 13:715-9. 2004
  7. ncbi request reprint Lack of association between the promoter polymorphisms at positions -308 and -238 of the tumor necrosis factor alpha gene and psoriasis vulgaris in Japanese patients
    Yuichiro Tsunemi
    Department of Dermatology, Faculty of Medicine, University of Tokyo, Tokyo, Japan
    Dermatology 207:371-4. 2003
  8. ncbi request reprint Both IL-4 and IL-13 inhibit the TNF-alpha and IFN-gamma enhanced MDC production in a human keratinocyte cell line, HaCaT cells
    Ting Xiao
    Department of Dermatology, Faculty of Medicine, University of Tokyo, Hongo 7 3 1, Bunkyo ku, 113 8655, Tokyo, Japan
    J Dermatol Sci 31:111-7. 2003
  9. ncbi request reprint Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris
    Takashi Kakinuma
    Department of Dermatology, University of Tokyo, Tokyo, Japan
    J Allergy Clin Immunol 111:592-7. 2003

Detail Information

Publications9

  1. doi request reprint Dramatic impact of a Psoriasis Area and Severity Index 90 response on the quality of life in patients with psoriasis: an analysis of Japanese clinical trials of infliximab
    Hideshi Torii
    Division of Dermatology, Social Insurance Central General Hospital, Tokyo, Japan
    J Dermatol 39:253-9. 2012
    ..Infliximab is considered a useful drug in meeting the treatment goal of achieving a DLQI of 0 or 1 through the attainment of a PASI 90 response...
  2. ncbi request reprint Clinical and bacteriological evaluation of adapalene 0.1% gel plus nadifloxacin 1% cream versus adapalene 0.1% gel in patients with acne vulgaris
    Masahiro Takigawa
    Hamamatsu University School of Medicine, Tokyo, Japan
    J Dermatol 40:620-5. 2013
    ..Thus, the simultaneous use of adapalene and nadifloxacin may provide an additive and complementary effect, resulting in clinical superiority and greater patient adherence compared to adapalene monotherapy. ..
  3. ncbi request reprint Dermatological side-effects of telaprevir-based triple therapy for chronic hepatitis C in phase III trials in Japan
    Hideshi Torii
    Division of Dermatology, Social Insurance Central General Hospital, Tokyo, Japan
    J Dermatol 40:587-95. 2013
    ..For appropriate treatments of individual dermatological adverse reactions, the judgment of discontinuation of antiviral drugs and treatment based on the severity are extremely important in this triple therapy. ..
  4. doi request reprint Infliximab monotherapy in Japanese patients with moderate-to-severe plaque psoriasis and psoriatic arthritis. A randomized, double-blind, placebo-controlled multicenter trial
    Hideshi Torii
    Division of Dermatology, Social Insurance Central General Hospital, and Department of Dermatology, The Jikei University School of Medicine, 3 22 1 Hyakunincho, Shinjyuku, Tokyo 169 0073, Japan
    J Dermatol Sci 59:40-9. 2010
    ..A clinical trial of infliximab in psoriasis has not yet been performed in Asian populations, although infliximab has been approved for the indications of psoriatic arthritis and plaque psoriasis in the US and the EU...
  5. ncbi request reprint Long-term study of infliximab in Japanese patients with plaque psoriasis, psoriatic arthritis, pustular psoriasis and psoriatic erythroderma
    Hideshi Torii
    Division of Dermatology, Social Insurance Central General Hospital, Tokyo, Japan
    J Dermatol 38:321-34. 2011
    ..In patients with plaque psoriasis, psoriatic arthritis, pustular psoriasis and psoriatic erythroderma, infliximab was well tolerated, regardless of prior treatment, and also showed superior efficacy over a period of approximately 1 year...
  6. ncbi request reprint The -431C>T polymorphism of thymus and activation-regulated chemokine increases the promoter activity but is not associated with susceptibility to atopic dermatitis in Japanese patients
    Yuichiro Tsunemi
    Department of Dermatology, Faculty of Medicine, University of Tokyo, Tokyo, Japan
    Exp Dermatol 13:715-9. 2004
    ..Thymus and activation-regulated chemokine (TARC) plays an important role in the pathogenesis of atopic dermatitis (AD). We recently detected the single nucleotide polymorphism (SNP) (-431C>T) in the 5'-flanking region of TARC gene...
  7. ncbi request reprint Lack of association between the promoter polymorphisms at positions -308 and -238 of the tumor necrosis factor alpha gene and psoriasis vulgaris in Japanese patients
    Yuichiro Tsunemi
    Department of Dermatology, Faculty of Medicine, University of Tokyo, Tokyo, Japan
    Dermatology 207:371-4. 2003
    ....
  8. ncbi request reprint Both IL-4 and IL-13 inhibit the TNF-alpha and IFN-gamma enhanced MDC production in a human keratinocyte cell line, HaCaT cells
    Ting Xiao
    Department of Dermatology, Faculty of Medicine, University of Tokyo, Hongo 7 3 1, Bunkyo ku, 113 8655, Tokyo, Japan
    J Dermatol Sci 31:111-7. 2003
    ..However, the regulation of MDC production in KCs by various cytokines has not been well documented...
  9. ncbi request reprint Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris
    Takashi Kakinuma
    Department of Dermatology, University of Tokyo, Tokyo, Japan
    J Allergy Clin Immunol 111:592-7. 2003
    ..It is selectively expressed in skin and attracts CC chemokine receptor 10-expressing skin-homing memory T cells. The epidermal keratinocyte is a main source of CTACK, suggesting the involvement of various inflammatory skin diseases...